AACR 2023 Recap with Dr. Christopher Klebanoff

CRI CLIP Investigator Christopher Klebanoff, MD, discusses neoantigen-targeting cell therapies at AACR 2023.

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.

[earleneschmitt]

I think would be interesting to express mutant archaic NOVA1 in cancer stem cells, and see if it drives the cancer toward terminal differentiation. It could be a tool to find more precise targets..